New coumarin–chalcone–triazole hybrids as promising anti-diabetic agents: from molecular design to in vivo validation

BW, outperforming acarbose at a comparable dose. These comprehensive findings identify compound 20q as a highly potent, selective, and safe α-glucosidase inhibitor with significant potential for further development as an antidiabetic agent.